3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Black women may overestimate cancer screening rates

CancerApr 28, 08

Many African-American women may overestimate the number of cancer screening tests they have had, potentially putting them at risk of late cancer detection, a small study suggests.

Researchers at the American Cancer Society found that among 116 black women they interviewed about their cancer screening history, there were generally large discrepancies between the women’s memories and their medical records.

In most of these cases, women remembered having a test that, based on the records, was not done, the researchers report in the journal Oncology Nursing Forum.

For example, 86 percent of those who were age 20 or older said they had had a clinical breast exam at some point in their lives, while 67 percent said they’d had one in the past year. According to their medical records, however, only 35 percent had ever had a clinical breast exam, and 26 percent had had one in the past year.

Experts recommend that women in their 20s and 30s have a clinical breast exam to search for lumps every 3 years; women older than 40 should have one annually.

Similarly, the study found, women reported higher rates of screening mammography, Pap tests for cervical cancer, and fecal occult blood tests (FOBTs) for colon cancer than their medical records showed.

In general, estimates of Americans’ cancer screening rates are based on self-reports. The current findings suggest that the true rates may be lower than those estimates, especially among African-American women.

“Self-reported screening rates are the foundation for many policy decisions that have a significant influence on the availability of resources for this population,” lead researcher Dr. Barbara D. Powe said in a statement.

“Indeed,” she added, “over- or underestimation of screening can be even more significant for African Americans, who bear a disproportionate cancer burden.”

Compared with whites, African Americans have higher death rates from breast cancer, cervical cancer and colon cancer. Lower screening rates, which lessen the chance of early cancer detection, are believed to be an important reason.

Among women older than 40, the age at which routine mammography should normally begin, 77 reported ever having had a mammogram, while 29 percent said they’d had one in the past year. The actual rates, according to their medical records, were 40 percent and 9 percent, respectively.

Nearly all of the women said they had had a Pap test at some point in their lives, but medical records showed that only 58 percent had.

Among women older than 50, the age at which colon cancer screening should begin, 56 percent said they’d had an FOBT at least once before, while the rate based on medical records was just 11 percent.

It’s possible that in some cases, the women did have tests that were not documented on their records, according to Powe’s team. But the findings highlight a need to close the gap between women’s estimates of their screening history and their actual rates, the researchers say.

Health centers could help by developing better “patient reminder systems,” they note, and by giving patients written summaries of the tests and procedures they have at each office visit.

SOURCE: Oncology Nursing Forum, March 2008.

NEW YORK (Reuters Health)



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site